← Back to Search

Reduced Nicotine Messages for Smoking

N/A
Waitlist Available
Research Sponsored by Georgia State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Belonging to one of three groups of participants; 900 current exclusive smokers, 450 dual users (cigarettes and e-cigarettes), and 450 young adult (18-29) non-smokers, evenly split between men and women.
Enrolled in existing nationally representative panel where recruitment is based
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two weeks after exposure
Awards & highlights

Study Summary

The investigators will conduct a message-exposure experiment with nationally representative samples of smokers, dual-users (cigarettes and e-cigarettes), and young adult non-smokers (aged 18-29). Experimental messages will address the reduction of nicotine in cigarettes. Participants will also complete a follow-up survey after 2 weeks, measuring their recall of the messages and behaviors since message exposure.

Eligible Conditions
  • Smoking
  • Health Communication
  • Risky Behaviors
  • Tobacco Smoking

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after exposure
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after exposure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Perceived health risk of VLNCs (absolute)
Secondary outcome measures
Nicotine
Interest in trying reduced nicotine cigarettes
Perceived Message Effectiveness
+5 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: Reduced Nicotine MessagesExperimental Treatment1 Intervention
Participants will receive messages with information about reduced nicotine cigarettes.
Group II: Modified Risk MessagesExperimental Treatment1 Intervention
Participants will receive messages with information about e-cigarettes.
Group III: ControlExperimental Treatment1 Intervention
Participants will receive messages about bottled water which should have no impact on the outcomes of interest.
Group IV: Combined Message -- Reduced Nicotine + Modified Risk ExposureExperimental Treatment1 Intervention
Participants will receive messages about reduced nicotine cigarettes and about e-cigarettes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Reduced nicotine message exposure
2022
N/A
~1800
Modified risk message exposure
2022
N/A
~1800
Combined message exposure (reduced nicotine + modified risk)
2022
N/A
~1800
Control message exposure
2022
N/A
~1800

Find a Location

Who is running the clinical trial?

Georgia State UniversityLead Sponsor
56 Previous Clinical Trials
23,257 Total Patients Enrolled
1 Trials studying Smoking
1,200 Patients Enrolled for Smoking

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are enrollment opportunities still available for this experiment?

"As indicated on clinicaltrials.gov, this trial is not presently seeking participants; it was first posted on October 12th and last updated on the 27th of that same month. Nonetheless, there are 124 other experiments actively enrolling individuals at present."

Answered by AI
~745 spots leftby Mar 2025